#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16298	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2107	766.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1462	1462	C	969	C,A	914,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28956	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3570	807.8	0	.	n	.	0	T695C	SNP	695	695	T	994	994	C	833	C	788	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28956	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3570	807.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1937	1937	G	975	G,A	928,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28956	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3570	807.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2270	2270	C	914	C,T	854,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28956	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3570	807.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2344	2344	A	949	A	911	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28956	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3570	807.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2896	2896	C	912	C	862	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28956	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3570	807.8	0	HET	.	.	.	A2769G,T	.	2769	2769	A	3068	3068	A	929	A,G,T	508,370,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2190	folP	855	855	100.0	folP.l15.c4.ctg.1	1584	137.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1027	1029	AGC	224;226;223	A;G;C	214;214;212	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5646	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3399	165.6	1	SNP	p	S91F	1	.	.	271	273	TTC	628	630	TTC	200;200;200	T;T;C	190;190;187	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5646	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3399	165.6	1	SNP	p	G95N	0	.	.	283	285	GGC	640	642	GGC	195;198;200	G;G,A;C	185;185,1;185	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5646	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3399	165.6	1	SNP	p	D95G	1	.	.	283	285	GGC	640	642	GGC	195;198;200	G;G,A;C	185;185,1;185	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1752	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1531	114.0	1	SNP	p	G45D	0	.	.	133	135	GGC	583	585	GGC	228;229;232	G;G;C	215;215;217	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	912	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1095	83.1	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	206	A	200	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2881	196.4	1	SNP	p	D86N	0	.	.	256	258	GAC	570	572	GAC	235;235;235	G,T;A;C	223,1;224;223	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2881	196.4	1	SNP	p	S87R	1	.	.	259	261	CGT	573	575	CGT	239;247;249	C,T;G;T	225,1;237;234	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2881	196.4	1	SNP	p	R87W	0	.	.	259	261	CGT	573	575	CGT	239;247;249	C,T;G;T	225,1;237;234	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2881	196.4	1	SNP	p	R87I	0	.	.	259	261	CGT	573	575	CGT	239;247;249	C,T;G;T	225,1;237;234	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5700	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2881	196.4	1	SNP	p	S88P	0	.	.	262	264	TCC	576	578	TCC	249;249;251	T;C;C	236;237;238	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4776	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2616	181.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1529	1531	GGC	265;266;268	G;G;C,A	250;247;244,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1301	1303	GCA	229;232;236	G;C;A	216;219;220	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1304	1306	ATC	238;238;239	A;T;C,A	223;224;225,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1316	1318	GTG	231;232;232	G;T;G	225;224;222	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1316	1318	GTG	231;232;232	G;T;G	225;224;222	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1820	1822	ACC	212;214;212	A;C;C	196;200;200	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1874	1876	GCG	231;230;226	G;C,G;G	206;186,2;196	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1874	1876	GCG	231;230;226	G;C,G;G	206;186,2;196	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1997	1999	GGC	176;172;173	G;G;C	168;160;162	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2006	2008	GGC	171;171;169	G;G;C	158;158;155	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4284	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2493	171.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2024	2026	CCG	135;137;138	C,G;C;G	100,6;103;103	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6208	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3128	197.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1662	1664	CCG	219;219;220	C;C;G	204;204;207	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2360	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1943	120.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	564	564	C	169	C	162	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	377	379	GGA	264;264;267	G;G;A	252;252;254	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	0	.	p	.	0	F135L	NONSYN	403	405	TTT	638	640	CTT	224;226;224	C;T;T	216;216;216	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	0	.	p	.	0	R143G	NONSYN	427	429	AGA	662	664	GGA	212;215;215	G;G;A	202;205;200	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	0	.	p	.	0	D171G	NONSYN	511	513	GAT	746	748	GGT	216;214;213	G;G;T	211;210;198	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	0	.	p	.	0	G189S	NONSYN	565	567	GGC	800	802	AGC	250;248;248	A;G;C	237;233;234	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	866	866	T	235	T	220	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	1	SNP	p	G120K	0	.	.	358	360	GGT	593	595	GGT	227;227;233	G,A;G;T	220,1;220;222	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	1	SNP	p	A121N	0	.	.	361	363	GCC	596	598	GCC	230;228;229	G;C;C	222;222;225	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3090	porB1b	1035	1035	97.71	porB1b.l6.c4.ctg.1	1599	191.3	1	SNP	p	A121D	0	.	.	361	363	GCC	596	598	GCC	230;228;229	G;C;C	222;222;225	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11290	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4911	229.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1322	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1150	114.6	1	SNP	p	V57M	1	.	.	169	171	ATG	594	596	ATG	273;270;271	A;T;G	262;259;260	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
